This HTML5 document contains 38 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n10http://dx.doi.org/10.1001/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q72846753
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в червні 1966 scientific article published on 01 June 1966 artículu científicu espublizáu en xunu de 1966 im Juni 1966 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel
p:P577
wds:Q72846753-9246519F-C452-464B-A019-916B8522A13F
wdt:P577
1966-06-01T00:00:00Z
p:P2093
wds:Q72846753-C1AED7DD-890F-492B-82DA-64C7BAC36410
wdt:P2093
M F Armaly
rdfs:label
Dexamethasone ocular hypertension in the clinically normal eye. II. The untreated eye, outflow facility, and concentration Dexamethasone ocular hypertension in the clinically normal eye. II. The untreated eye, outflow facility, and concentration
skos:prefLabel
Dexamethasone ocular hypertension in the clinically normal eye. II. The untreated eye, outflow facility, and concentration Dexamethasone ocular hypertension in the clinically normal eye. II. The untreated eye, outflow facility, and concentration
schema:name
Dexamethasone ocular hypertension in the clinically normal eye. II. The untreated eye, outflow facility, and concentration Dexamethasone ocular hypertension in the clinically normal eye. II. The untreated eye, outflow facility, and concentration
p:P1476
wds:Q72846753-A7C4991F-508F-4DF1-8E89-0DFDCCAEF535
wdt:P1476
Dexamethasone ocular hypertension in the clinically normal eye. II. The untreated eye, outflow facility, and concentration
p:P304
wds:Q72846753-A2BCC00B-BAEC-4B11-B355-1BB590D51001
wdt:P304
776-782
p:P31
wds:Q72846753-9409116F-5436-40F1-A29C-FD416CA690B1
wdt:P31
wd:Q13442814
p:P921
wds:Q72846753-266445F4-CC40-435F-AFE2-B2FD24395FE0 wds:Q72846753-2D617B7B-926A-4603-BD80-E3DE72D25BC8
wdt:P921
wd:Q9294051 wd:Q422252
p:P698
wds:Q72846753-548CCAAB-FB81-45D1-8E3F-1178428825BD
wdtn:P698
n12:5936805
wdt:P698
5936805
p:P1433
wds:Q72846753-972F732E-AFF6-44E1-9499-DE7CCCA22AA3
wdt:P1433
wd:Q4787301
p:P433
wds:Q72846753-B7FA5F13-603F-440B-83E9-2234E24ACDEA
p:P478
wds:Q72846753-F725CCF2-4DE9-4CF0-848D-7F407BE32902
wdt:P433
6
wdt:P478
75
p:P356
wds:Q72846753-3DAB0409-88E0-44D5-8906-C397F4EFC805
wdtn:P356
n10:ARCHOPHT.1966.00970050778013
wdt:P356
10.1001/ARCHOPHT.1966.00970050778013